UPDATE : Monday, September 7, 2020
상단여백
Chong Kun Dang gets license for generic immunosuppressant
Chong Kun Dang said it has obtained approval for Raparobell, a generic copy...
by So Jae-hyeon  |  2018-08-03 15:38
라인
Korean drugmakers rush to establish US subsidiaries
Local pharmaceutical companies are rushing to establish subsidiaries in the...
by So Jae-hyeon  |  2018-08-03 14:40
라인
Pharmacists, convenience store owners in dispute over OTC drugs
The group of Korean pharmacists and that of convenience store owners are sl...
by So Jae-hyeon  |  2018-08-02 15:32
라인
Daewoong Bio’s dementia drug hits 3-digit sales growth
Industry watchers are paying attention to whether rising sales of generic d...
by So Jae-hyeon  |  2018-08-01 15:50
라인
Sales of osteoporosis drugs falter, combo therapies survive
The osteoporosis treatment market is stagnating with sales of major product...
by So Jae-hyeon  |  2018-07-31 15:37
라인
SillaJen, Medytox one step closer to entering China
Korean biotech firms SillaJen and Medytox said they have almost completed p...
by So Jae-hyeon  |  2018-07-31 13:09
라인
[News scene] Why did pharmacists take to street in hottest weather?
Despite the hot weather with daytime highs exceeding 37 degrees Celsius acr...
by So Jae-hyeon  |  2018-07-30 14:34
라인
Sales of impotence drugs slide
The growth of erectile dysfunction medicines is slowing, with the sales of ...
by So Jae-hyeon  |  2018-07-26 14:12
라인
Antidiabetic drug Zemiglo up, cancer drug Supect down in H1 sales
Locally developed new drugs showed mixed performances in prescriptions in t...
by So Jae-hyeon  |  2018-07-24 11:11
라인
Stock declines, negative rumors haunt biotech industry
The local biotech industry is struggling with negative rumors on leading fi...
by So Jae-hyeon  |  2018-07-23 16:39
라인
Latecomer Lixiana’s chase after Eliquis gets faster
Daiichi Sankyo’s Lixiana, a latecomer in the non-vitamin K antagonist oral ...
by So Jae-hyeon  |  2018-07-20 12:01
라인
Bifido wins patent for microbiome-based treatment in US
Bifido said it has become the first domestic company to win a patent for a ...
by So Jae-hyeon  |  2018-07-19 15:42
라인
Kolon Life Science inks deal to sell Invossa to China
Kolon Life Science said Wednesday it has signed a deal to sell 230 billion ...
by So Jae-hyeon  |  2018-07-18 16:46
라인
Dong-A ST’s Jublia dominates athlete’s foot drugs
The sales of Dong-A ST’s Jublia, a toenail fungal treatment, has grown rapi...
by So Jae-hyeon  |  2018-07-18 11:50
라인
Korean eye drops selling well overseas
Korean eye drops made by Huons, Sam Chun Dang Pharm, and Hanlim Pharm are i...
by So Jae-hyeon  |  2018-07-17 11:36
라인
When will Seoul update drug review system for cell therapies?
The Korean government’s drug insurance benefit and review system is so outd...
by So Jae-hyeon  |  2018-07-16 12:36
라인
Edarbi, Saxenda prescribed in major hospitals
A new hypertension drug Edarbi by Takeda Pharmaceuticals Korea and Dong-A S...
by So Jae-hyeon  |  2018-07-11 15:42
라인
Local drug makers strive to conquer neurological diseases
Korean pharmaceutical and biotech companies keep challenging to develop neu...
by So Jae-hyeon  |  2018-07-09 12:09
라인
Platform technologies key to developing new drugs
Major pharmaceutical firms such as Hanmi Pharmaceutical, Green Cross Lab Ce...
by So Jae-hyeon  |  2018-07-03 16:12
라인
SillaJen to develop biomarker for JX-970
SillaJen is rolling up its sleeves to develop a biomarker for an investigat...
by So Jae-hyeon  |  2018-07-03 14:19
-123456-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top